Shares of pharmaceutical major Lupin Ltd recovered and ended the session higher by 9.04 per cent at Rs 1,801.45 on the BSE.
Earlier, the stock plunged 2.8 per cent ahead of October-December quarter earnings. The results were expected during market hours.
Analysts on average expect the company to post a net profit of Rs 530 crore ($78 million) on a revenue of Rs 3,360 core, says Thomson Reuters I/B/E/S/
Traders say yen’s volatility might impact the company’s Japan business, which contributes 11 per cent to the revenue ($1 = 67.6350 Indian rupees).